(Q35824844)

10 August 2017

1 reference

title

Haemophilia and thrombophilia: an unexpected association! (English)

1 reference

10 August 2017

0 references

0 references

1 reference

0 references

Y Dargaud

1

1 reference

10 August 2017

S Meunier

series ordinal

2

1 reference

10 August 2017

C Negrier

series ordinal

3

1 reference

10 August 2017

language of work or name

1 reference

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

10

1 reference

10 August 2017

4

1 reference

10 August 2017

319-326

1 reference

The hemophilias--from royal genes to gene therapy

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Genetic susceptibility to venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Resistance to activated protein C as a basis for venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Mutation in blood coagulation factor V associated with resistance to activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Modifier genes in haemophilia: their expansion in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Combined factor IX and protein C deficiency in a child: thrombogenic effects of two factor IX concentrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Deep venous thrombosis in hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Thrombogenicity of prothrombin complex concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Monitoring the bioavailability of FEIBA with a thrombin generation assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Evidence for the use of activated prothrombin complex concentrates (aPCCs) in the treatment of patients with haemophilia and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Mechanism of action of high-dose factor VIIa: points of agreement and disagreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Influence of factor VIIa and phospholipids on coagulation in "acquired" hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Platelet activity of high-dose factor VIIa is independent of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Mechanism of factor VIIa-dependent coagulation in hemophilia blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Central venous catheter‐related thrombosis presenting as superior vena cava syndrome in a haemophilic patient with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

AIDS and thrombosis: retrospective study of 131 HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

HIV and thrombosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Contrast venography in young haemophiliacs with implantable central venous access devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

The use of central venous catheters (portacaths) in children with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Complications experienced with central venous catheters in children with congenital bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Central venous catheter-associated thrombosis in severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Thrombosis in a duplicated superficial femoral vein in a patient with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Optimal duration of anticoagulant therapy after an episode of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

How we diagnose and treat deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

Does inflammation contribute to thrombotic events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2004.00906.X

10.1111/J.1365-2516.2004.00906.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference